Biopharmaceuticals and gene therapy Flashcards

1
Q

what is biopharmaceuticals?

A

A biological molecule used as a pharmaceutical.

can either be protein or oligonucleotide in nature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is first generation biopharmaceuticals?

A

biological molecules in its endogenous form.
They have not been modified.
For example human insulin and Human growth hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is second generation biopharmaceutical?

A

Biological molecules that have undergone modification therefore altering the nature of the product.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what production method is used in biopharmaceuticals?

A

bacterial expression system:

human gene is combined with bacterial plasmid to form a recombinant plasmid.

bacterial transformation results in heterologous expression.

protein purification the takes pace.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the advantage of this production method?

A

high yield end product

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the disadvantages of this method?

A

may contain endotoxins

post-translational processing may differ compared to mammalian cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are alternative expression systems?

A

transgenic cattle
plant: tobacco/edible plants
Chinese hamster ovary cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the advantage of using transgenic cattle and plants for alternative expression systems?

A

genes can be put into tobacco more easily = quicker and efficient

transgenic cattle produce milk with proteins that utilise production of proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are some problems with first generation mAbs?

A

can provoke an immune response
short half-life
also can’t activate human complements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how can the lack of activation of human complements be addressed?

A

By humanising the antibodies (forming a chimera)
A mix between human and mice
effective therapeutics can be achieved from this due to the specificity formed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is an alternative approach to delivering entire genes?

A

using oligonucleotides

short antisense oligonucleolotides specifically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is mipomersen used for?

A

to treat hypercholesterolaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the comparison in size between conventional drugs and biopharmaceuticals?

A

biopharmaceuticals are larger in size compared to conventional drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is the comparison in synthesis between conventional drugs and biopharmaceuticals?

A

conventional drugs are easier to synthesise in identical batches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the relationship between dose and effect for conventional drugs and biopharmaceuticals?

A

conventional drugs have a more predictable relationship between dose and effect whereas biopharmaceuticals are less predictable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is gene therapy?

A

a strategy used to deliver a functioning copy of a defective gene to a target cell by using a suitable vector.

17
Q

give an example of second generation biopharmaceuticals?

A

insulin synthesised to have a longer duration of action

18
Q

what is an advantage of biopharmaceuticals over conventional drugs?

A

biopharmaceuticals have a lower incidence of adverse effects

19
Q

how does an antisense oligonucleotide bring about its therapeutic effect?

A

by blocking the translation of mRNA once it has reached the ribosome

20
Q

give some example of the therapeutic applications of gene therapy:

A

gendicine: treatment of replacing faulty P53 protein causing head and neck cancer
glybera: Aden-associated virus construct
strimvelis: ex-vivo therapy to reat SCID